Evaluation of Angiographic Parameters in Patients with Chronic Heart Failure
Keywords:
Chronic heart failure, Coronary angiography, Revascularization
Abstract
The article presents data on the study of the features of angiographic changes in patients with chronic heart failure (CHF). The aim of the study is to determine the relationship of clinical and angiographic data with the clinical course of the disease. The study involved 112 patients with FC II-III CHF aged 52.52 ± 6.21 years, who were inpatient treatment at the regional multicenter medical center of the Bukhara region. In patients with CHF, coronary artery lesions had a relationship with the severity of the disease; in patients with CHF II-III FC, the degree of coronary artery stenosis had a direct correlation with the), a clinical condition assessment scale indicator, and an inverse correlation with the six-minute walk test and LVEF.
References
1. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. 2016, European Heart Journal, 37 (27): 2129-2200.
2. Jeremias A, Kaul S, Rosengart TK, Gruberg L, Brown DL. 2009, The impact of revascularization on mortality in patients with nonacute coronary artery disease. Am J Med., 122: 152–161.
3. Bangalore S, Guo Y, Samadashvili Z, Blecker S, Hannan EL. 2016, Revascularization in patients with multivessel coronary artery disease and severe left ventricular systolic dysfunction: everolimus-eluting stents versus coronary artery bypass graft surgery. Circulation, 133(22): 2132-40.
4. Cardona M., Martín V., Prat-Gonzalez S., Ortiz J.T. et al. 2016, Benefits of chronic total coronary occlusion percutaneous intervention in patients with heart failure and reduced ejection fraction: insights from a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson., Nov 5; 18(1): 78.
5. Cleland JGF, Calvert M, Freemantle N. et al. 2011, The Heart Failure Revascularization Trial (HEART). Eur J Heart Fail., 13(2): 227-33.
6. Windecker S, Stortecky S, Stefanini GG. 2014, Revascularization versus medical treatment in patients with stable coronary artery disease: Network meta-analysis. BMJ., 348: g3859.
7. Yancy CW, Jessup M, Bozkurt B. et al. 2013, CCF/AHA Guideline for the management of heart failure: executive summary. A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation, 128(16): 1810-52.
8. 2018 ESC/EACTS Guidelines on myocardial revascularization. 2019, European Heart Journal, 40: Is. 2, P.87–165.
9. Jeremias A, Kaul S, Rosengart TK, Gruberg L, Brown DL. 2009, The impact of revascularization on mortality in patients with nonacute coronary artery disease. Am J Med 122: 152–161.
10. Pyka L., Hawranek M., Gąsior M. 2017, Revascularization in ischemic heart failure with reduced left ventricular ejection fraction. The impact of complete revascularization. Kardiochir Torakochirurgia Pol. Mar; 14(1): 37–42.
11. Hwang S.J., Melenovsky V., Borlaug B.A. 2014, Implications of coronary artery disease in heart failure with preserved ejection fraction. J Am Coll Cardiol, 63: 2817–2827.
12. Hoebers L.P., Claessen B.E., Elias J., Dangas G.D. et al. 2015, Meta-analysis on the impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcome. Int J Cardiol. 187: 90–6.
13. Khariton Y., Airhart S., Salisbury A.C., Spertus J.A. et al. 2018, Health Status Benefits of Successful Chronic Total Occlusion Revascularization Across the Spectrum of Left Ventricular Function: Insights From the OPEN-CTO Registry. JACC Cardiovasc Interv. Nov 26; 11(22): 2276–2283. doi: 10.1016/j.jcin.2018.07.058.
14. Megaly M, Saad M, Tajti P, Burke MN et al. 2018, Meta-analysis of the impact of successful chronic total occlusion percutaneous coronary intervention on left ventricular systolic function and reverse remodeling. J Interv Cardiol. Oct; 31(5): 562-571
2. Jeremias A, Kaul S, Rosengart TK, Gruberg L, Brown DL. 2009, The impact of revascularization on mortality in patients with nonacute coronary artery disease. Am J Med., 122: 152–161.
3. Bangalore S, Guo Y, Samadashvili Z, Blecker S, Hannan EL. 2016, Revascularization in patients with multivessel coronary artery disease and severe left ventricular systolic dysfunction: everolimus-eluting stents versus coronary artery bypass graft surgery. Circulation, 133(22): 2132-40.
4. Cardona M., Martín V., Prat-Gonzalez S., Ortiz J.T. et al. 2016, Benefits of chronic total coronary occlusion percutaneous intervention in patients with heart failure and reduced ejection fraction: insights from a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson., Nov 5; 18(1): 78.
5. Cleland JGF, Calvert M, Freemantle N. et al. 2011, The Heart Failure Revascularization Trial (HEART). Eur J Heart Fail., 13(2): 227-33.
6. Windecker S, Stortecky S, Stefanini GG. 2014, Revascularization versus medical treatment in patients with stable coronary artery disease: Network meta-analysis. BMJ., 348: g3859.
7. Yancy CW, Jessup M, Bozkurt B. et al. 2013, CCF/AHA Guideline for the management of heart failure: executive summary. A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation, 128(16): 1810-52.
8. 2018 ESC/EACTS Guidelines on myocardial revascularization. 2019, European Heart Journal, 40: Is. 2, P.87–165.
9. Jeremias A, Kaul S, Rosengart TK, Gruberg L, Brown DL. 2009, The impact of revascularization on mortality in patients with nonacute coronary artery disease. Am J Med 122: 152–161.
10. Pyka L., Hawranek M., Gąsior M. 2017, Revascularization in ischemic heart failure with reduced left ventricular ejection fraction. The impact of complete revascularization. Kardiochir Torakochirurgia Pol. Mar; 14(1): 37–42.
11. Hwang S.J., Melenovsky V., Borlaug B.A. 2014, Implications of coronary artery disease in heart failure with preserved ejection fraction. J Am Coll Cardiol, 63: 2817–2827.
12. Hoebers L.P., Claessen B.E., Elias J., Dangas G.D. et al. 2015, Meta-analysis on the impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcome. Int J Cardiol. 187: 90–6.
13. Khariton Y., Airhart S., Salisbury A.C., Spertus J.A. et al. 2018, Health Status Benefits of Successful Chronic Total Occlusion Revascularization Across the Spectrum of Left Ventricular Function: Insights From the OPEN-CTO Registry. JACC Cardiovasc Interv. Nov 26; 11(22): 2276–2283. doi: 10.1016/j.jcin.2018.07.058.
14. Megaly M, Saad M, Tajti P, Burke MN et al. 2018, Meta-analysis of the impact of successful chronic total occlusion percutaneous coronary intervention on left ventricular systolic function and reverse remodeling. J Interv Cardiol. Oct; 31(5): 562-571
Published
2022-08-01
How to Cite
Musaeva, R. K. (2022). Evaluation of Angiographic Parameters in Patients with Chronic Heart Failure. Central Asian Journal of Medical and Natural Science, 3(4), 166-170. https://doi.org/10.17605/cajmns.v3i4.992
Issue
Section
Articles
